13FPulse
中
CO

COYA COYA THERAPEUTICS INC

2026Q1 · CUSIP 22407B108 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
56
Δ holders QoQ
-2
Breadth percentile
Top 70%
Whale holders
27
Δ whales
-1
Inst. holding value
$32M
New positions
13
Closed positions
15
Price momentum (1Q)
—
Put / Call
0/1

Breadth history (34 quarters)

2023Q1: holders=8 2023Q2: holders=15 2023Q3: holders=16 2023Q4: holders=22 2024Q1: holders=20 2024Q2: holders=20 2024Q3: holders=20 2024Q4: holders=27 2025Q1: holders=27 2025Q2: holders=34 2025Q3: holders=37 2025Q4: holders=58 2026Q1: holders=56 -21 -10.5 +0 +10.5 +21 73461 23Q123Q223Q323Q424Q124Q224Q324Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
0
QoQ: 0
Call holders
1
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.15
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
+115.4%
Net margin
-266.1%
ROE
-43.1%
Debt ratio
8.1%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
2023-03-31: EPS -0.28 2023-06-30: EPS -0.31 2023-09-30: EPS -0.34 2024-03-31: EPS -0.35 2024-06-30: EPS -0.19 2024-09-30: EPS -0.26 2024-12-31: EPS -0.18 2025-03-31: EPS -0.44 2025-06-30: EPS -0.36 2025-09-30: EPS -0.13 2025-12-31: EPS -0.34 2026-03-31: EPS -0.32 0M 3M 6M $M -0.48 -0.24 0.00 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)

Get the next update

2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.